Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition (Companion Faculty Lecture)

Featuring a slide presentation and related discussion from Dr Kanwal Raghav, including the following topics:

Prevalence of HER2 alterations among patients with advanced gastrointestinal tumors beyond gastroesophageal cancer (0:00)

Dual HER2 inhibition in the treatment of HER2-amplified colorectal cancer (CRC) (4:56)

Efficacy and tolerability of the antibody-drug conjugate trastuzumab deruxtecan (T-DXd) for patients with HER2-expressing metastatic CRC (8:52)

Activity and safety of the novel bispecific antibody zanidatamab for previously treated HER2-amplified biliary tract cancer (BTC) (14:11)…

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.